|
DCLRE1A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.57779994519802E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.50439999966079E-07 |
| Normal-vs-Stage2 |
1.223370E-04 |
| Normal-vs-Stage3 |
1.57249999688247E-08 |
| Normal-vs-Stage4 |
4.08449996047722E-09 |
| Stage1-vs-Stage2 |
8.248200E-01 |
| Stage1-vs-Stage3 |
8.647800E-02 |
| Stage1-vs-Stage4 |
2.164400E-02 |
| Stage2-vs-Stage3 |
1.539370E-01 |
| Stage2-vs-Stage4 |
2.410300E-02 |
| Stage3-vs-Stage4 |
3.553400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.03480002344725E-09 |
| Normal-vs-AfricanAmerican |
5.398200E-03 |
| Normal-vs-Asian |
4.6498000000339E-06 |
| Caucasian-vs-AfricanAmerican |
2.746400E-01 |
| Caucasian-vs-Asian |
6.942400E-01 |
| AfricanAmerican-vs-Asian |
4.407600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.88260000314011E-08 |
| Normal-vs-Female |
2.04450000262923E-08 |
| Male-vs-Female |
3.165200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.40540000029377E-07 |
| Normal-vs-Age(41-60Yrs) |
6.24679996619193E-09 |
| Normal-vs-Age(61-80Yrs) |
1.74343000000077E-05 |
| Normal-vs-Age(81-100Yrs) |
8.584900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.308800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.095400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.640800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.291200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.027600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.761600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.399100E-03 |
| Classical-VS-Follicular |
2.384400E-02 |
| Classical-VS-Other |
3.810400E-01 |
| Classical-VS-Normal |
1.0345999945649E-08 |
| Tall-VS-Follicular |
1.016860E-04 |
| Tall-VS-Other |
8.068200E-01 |
| Tall-VS-Normal |
2.1578000497513E-09 |
| Follicular-VS-Other |
1.478180E-01 |
| Follicular-VS-Normal |
5.701700E-03 |
| Other-VS-Normal |
5.319700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.07719999997702E-06 |
| Normal-vs-N1 |
3.31799998587456E-09 |
| N0-vs-N1 |
1.376260E-02 |
|
|
